Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1802637-39-3 Chemical Structure| 1802637-39-3

Structure of BB-Cl-Amidine
CAS No.: 1802637-39-3

Chemical Structure| 1802637-39-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BB-Cl-amidine is a irreversible peptidylarginine deminase (PAD) inhibitor.

Synonyms: BB-Cl-Amidine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BB-Cl-Amidine

CAS No. :1802637-39-3
Formula : C26H26ClN5O
M.W : 459.97
SMILES Code : O=C(C1=CC=C(C2=CC=CC=C2)C=C1)N[C@H](C3=NC4=CC=CC=C4N3)CCCNC(CCl)=N
Synonyms :
BB-Cl-Amidine
MDL No. :MFCD31746879
InChI Key :YDOAWJHYHGBQFI-QHCPKHFHSA-N
Pubchem ID :129021946

Safety of BB-Cl-Amidine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H314
Precautionary Statements:P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501
Class:8
UN#:1759
Packing Group:

Related Pathways of BB-Cl-Amidine

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U2OS cells 8.8 µM Evaluate cytotoxicity of BB-Cl-Amidine Acc Chem Res. 2019 Mar 19;52(3):818-832
human peripheral blood monocytes (CD14+ monocytes) 1 μM 1 h Inhibited STING-dependent signaling, reduced IFNβ production Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305420120
bone marrow-derived macrophages (BMDMs) 1 μM 1 h Inhibited STING-dependent signaling, reduced TNF-α and IFNβ production Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305420120
Primary cortical neurons 0.01, 0.05, 0.1, 0.5 nM 3 h To evaluate the protective effect of BB-Cl-Amidine against oxygen-glucose deprivation (OGD) and NMDA-induced neuronal death. Results showed that BB-Cl-Amidine pretreatment significantly reduced OGD- and NMDA-induced neuronal death in a dose-dependent manner. Acta Neuropathol Commun. 2025 Feb 18;13(1):33
PMNs 1-20 μM 4, 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
PBMCs 1-20 μM 24, 48, 72 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
CID-9 mouse mammary epithelial cells 2 µM 12 h Inhibited PAD activity, significantly blocking prolactin-induced increase in β-casein and butyrophilin mRNA expression. Int J Mol Sci. 2020 Apr 10;21(7):2634
monocytes 20 µM 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
NK cells 20 µM 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
B cells 20 µM 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
CD8+T cells 20 µM 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250
CD4+T cells 20 µM 24 h To evaluate the effect of BB-Cl-Amidine on cell viability, results showed that BB-Cl-Amidine was cytotoxic at concentrations above 1 mM Front Immunol. 2021 Oct 19;12:716250

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Trex1D18N/D18N mutant mice Intraperitoneal injection 10 mg/kg Daily for 8 weeks Alleviated STING-dependent inflammatory pathology, improved survival, reduced splenomegaly and myocarditis Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305420120
Sprague-Dawley rats Middle cerebral artery occlusion (MCAO) model Intranasal administration 5, 10, 50 µg/kg Immediate administration (0 h) or delayed administration (48/72 h) To evaluate the protective effect of BB-Cl-Amidine on ischemic brain injury. Results showed that BB-Cl-Amidine significantly reduced infarct volume, improved neurological and motor functions, and suppressed delayed NETosis induction. Acta Neuropathol Commun. 2025 Feb 18;13(1):33
MRL/lpr mice Systemic lupus erythematosus model Subcutaneous injection 1 mg/kg/day Once daily for 6 weeks To evaluate the effect of BB-Cl-Amidine on NET formation and SLE-related damage, results showed that BB-Cl-Amidine significantly reduced NET formation, improved vascular function, and reduced kidney and skin damage Ann Rheum Dis. 2015 Dec;74(12):2199-206
NOD mice NOD mouse diabetes model Subcutaneous injection 1 mg/g Six times per week until 25 weeks of age BB-Cl-amidine treatment fully prevented diabetes development in NOD mice, associated with reduced levels of citrullination in the pancreas, decreased circulating autoantibody titers against citrullinated GRP78, and reduced spontaneous neutrophil extracellular trap formation of bone marrow–derived neutrophils. Additionally, BB-Cl-amidine treatment induced a shift from Th1 to Th2 cytokines in the serum and an increase in the frequency of regulatory T cells in the blood and spleen. In the pancreas, BB-Cl-amidine treatment preserved insulin production and was associated with a less destructive immune infiltrate characterized by reduced frequencies of effector memory CD4+T cells and a modest reduction in the frequency of interferon-g–producing CD4+ and CD8+T cells. Diabetes. 2021 Feb;70(2):516-528

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.87mL

2.17mL

1.09mL

21.74mL

4.35mL

2.17mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories